NCT02721589 2023-02-28A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Solid Tumor SubjectsJiangsu HengRui Medicine Co., Ltd.Phase 1 Completed126 enrolled
NCT05214976 2022-12-22A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of PatientsJiangsu HengRui Medicine Co., Ltd.Phase 2 Unknown64 enrolled